Richard A. Graham is VP at Theravance Biopharma, Inc. (TBPH). They have made 4 open-market trades across 1 company since 2020, most recently 2024-02-20.
CIK 0001820036
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TBPH | 314,915 | $5.4M |
Shares reported on the most recent Form 4, priced at the 2024-02-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBPH | SELL · 10b5-1 | 2023-11-14 | 2023-11-16 | $10.22 | $25K | +1.7% | +8.4% | -17.9% |
| TBPH | SELL · 10b5-1 | 2023-10-16 | 2023-10-18 | $9.03 | $22K | +2.2% | +14.8% | +5.8% |
| TBPH | SELL · 10b5-1 | 2023-09-14 | 2023-09-18 | $9.89 | $25K | -5.8% | +2.8% | +25.5% |
| TBPH | SELL · 10b5-1 | 2023-08-11 | 2023-08-15 | $9.99 | $23K | -6.5% | -4.0% | +0.9% |
| TBPH | SELL · 10b5-1 | 2023-07-14 | 2023-07-18 | $9.84 | $23K | -1.9% | -3.4% | -9.1% |
| TBPH | SELL · 10b5-1 | 2023-06-14 | 2023-06-16 | $10.69 | $25K | -2.6% | -9.0% | -8.1% |
| TBPH | SELL · 10b5-1 | 2023-05-15 | 2023-05-17 | $11.26 | $26K | +3.1% | -1.7% | -5.7% |
| TBPH | SELL · 10b5-1 | 2023-04-14 | 2023-04-18 | $11.88 | $28K | -6.6% | -6.1% | -17.1% |
| TBPH | SELL · 10b5-1 | 2023-03-14 | 2023-03-16 | $10.32 | $24K | -0.6% | +11.2% | -2.2% |
| TBPH | SELL · 10b5-1 | 2023-03-06 | 2023-03-08 | $10.05 | $23K | +3.1% | +8.9% | +8.1% |
| TBPH | SELL | 2022-12-01 | 2022-12-05 | $10.73 | $22K | -0.2% | +0.3% | -6.4% |
| TBPH | SELL | 2022-08-16 | 2022-08-18 | $9.71 | $48K | -2.3% | +11.0% | +21.8% |
| TBPH | SELL | 2022-08-09 | 2022-08-11 | $8.79 | $265K | -3.6% | -1.7% | +15.6% |
| TBPH | SELL | 2020-12-14 | 2020-12-16 | $19.47 | $146K | -5.9% | -5.1% | +8.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.